Abstract
Human mesenchymal stem cells (hMSCs) are being considered for clinical trials of multiple sclerosis (MS).
We examined the effects of adult bone marrow-derived hMSCs on responses of primary human Th1, Th17, and Th1/17 double-expressing T-cell subsets, all implicated in MS.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1482